Polyclonal antibody Diffistat-G

Drug Profile

Polyclonal antibody Diffistat-G

Alternative Names: Diffistat-G

Latest Information Update: 23 Dec 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GalaGen
  • Class Polyclonal antibodies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Clostridium-difficile-infections

Most Recent Events

  • 23 Dec 1999 Discontinued-II for Clostridium difficile infections in USA (PO)
  • 25 Nov 1998 Suspended-II for Clostridium difficile infections in USA (PO)
  • 22 Aug 1997 Phase-II clinical trials for Clostridium difficile infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top